Kaplan-Meier graphs for recurrence-free survival in the whole population or only in patients with luminal A, luminal B or basal-like breast cancer showed that high IL-17B expression was significantly correlated with poorer prognosis in the whole population (Figure 1D, p = 0.032 and 15% probability decrease) and in the basal-like subtype (Figure 1E, p = 0.019 and 15% probability decrease), but not in the other subtypes (Figure 1F and 1G). This evidence concerns the gene IL17B and breast carcinoma.